Clever Leaves (CLVR) Competitors

Clever Leaves (NASDAQ:CLVR) and Ampio Pharmaceuticals (NYSE:AMPE) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, profitability, dividends, valuation, earnings, risk and analyst recommendations.

Is CLVR or AMPE more profitable?

Company	Net Margins	Return on Equity	Return on Assets
Clever Leaves	N/A	N/A	N/A
Ampio Pharmaceuticals	N/A	N/A	N/A

Which has better earnings & valuation, CLVR or AMPE?

Ampio Pharmaceuticals has lower revenue, but higher earnings than Clever Leaves. Ampio Pharmaceuticals is trading at a lower price-to-earnings ratio than Clever Leaves, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Clever Leaves	$17.42M	0.00	-$17.90M	-$11.31	0.00
Ampio Pharmaceuticals	N/A	N/A	-$8.63M	-$11.01	0.00

Which has more risk & volatility, CLVR or AMPE?

Clever Leaves has a beta of 3696.52, suggesting that its stock price is 369,552% more volatile than the S&P 500. Comparatively, Ampio Pharmaceuticals has a beta of 5.09, suggesting that its stock price is 409% more volatile than the S&P 500.

Does the media prefer CLVR or AMPE?

In the previous week, Clever Leaves' average media sentiment score of 0.00 equaled Ampio Pharmaceuticals'average media sentiment score.

Company	Overall Sentiment
Clever Leaves	Neutral
Ampio Pharmaceuticals	Neutral

Do insiders & institutionals have more ownership in CLVR or AMPE?

6.9% of Clever Leaves shares are held by institutional investors. Comparatively, 5.7% of Ampio Pharmaceuticals shares are held by institutional investors. 8.2% of Clever Leaves shares are held by company insiders. Comparatively, 3.3% of Ampio Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Clever Leaves beats Ampio Pharmaceuticals on 5 of the 7 factors compared between the two stocks.